These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34944596)

  • 1. Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design.
    Kaynarcalidan O; Moreno Mascaraque S; Drexler I
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1.
    Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C
    Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
    Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
    mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
    Volz A; Sutter G
    Adv Virus Res; 2017; 97():187-243. PubMed ID: 28057259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.
    Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR
    J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical development of Modified Vaccinia virus Ankara vaccines.
    Gilbert SC
    Vaccine; 2013 Sep; 31(39):4241-6. PubMed ID: 23523410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.
    Pavot V; Sebastian S; Turner AV; Matthews J; Gilbert SC
    Methods Mol Biol; 2017; 1581():97-119. PubMed ID: 28374245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
    Ryerson MR; Shisler JL
    Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications.
    Orlova OV; Glazkova DV; Bogoslovskaya EV; Shipulin GA; Yudin SM
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
    Yoshikawa T
    Vaccine; 2021 Oct; 39(41):6174-6181. PubMed ID: 34521550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
    de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulent Poxviruses Inhibit DNA Sensing by Preventing STING Activation.
    Georgana I; Sumner RP; Towers GJ; Maluquer de Motes C
    J Virol; 2018 May; 92(10):. PubMed ID: 29491158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
    Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.
    Price PJ; Torres-Domínguez LE; Brandmüller C; Sutter G; Lehmann MH
    Vaccine; 2013 Sep; 31(39):4231-4. PubMed ID: 23523404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies.
    Volz A; Sutter G
    Vaccine; 2013 Sep; 31(39):4235-40. PubMed ID: 23523402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.